Dr. Megan A Baumgart

Claim this profile
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
5 drugs studied

Area of expertise

1Lung Cancer
Megan A Baumgart has run 1 trial for Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
PD-L1 positive
2Non-Small Cell Lung Cancer
Megan A Baumgart has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
PD-L1 positive

Clinical Trials Megan A Baumgart is currently running

More about Megan A Baumgart

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Megan A Baumgart has experience with
  • Carboplatin
  • Nab-paclitaxel
  • Paclitaxel
  • Pembrolizumab
  • Pemetrexed

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Megan A Baumgart specialize in?
Megan A Baumgart focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Megan A Baumgart currently recruiting for clinical trials?
Yes, Megan A Baumgart is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Megan A Baumgart has studied deeply?
Yes, Megan A Baumgart has studied treatments such as Carboplatin, Nab-paclitaxel, Paclitaxel.
What is the best way to schedule an appointment with Megan A Baumgart?
Apply for one of the trials that Megan A Baumgart is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.